Wu Yu, Gao Lina, Lazo Jose, Martinez Brandon, Grewal Simran, Yurkova Irina, Galeota Julia, Nash Catherine, Cutler Meghan, Tarango Nimaljeet, Prasad Pooja, Cheng Richard, Motiwala Shweta, De Marco Teresa
Department of Surgery, Division of Cardiothoracic Surgery, Section of Mechanical Circulatory Support, University of California San Francisco Health, San Francisco, CA 94143, USA.
Department of Medicine, Division of Cardiology, Section of Advanced Heart Failure and Heart Transplant, University of California San Francisco Health, San Francisco, CA 94143, USA.
J Clin Med. 2025 Feb 18;14(4):1346. doi: 10.3390/jcm14041346.
Heart transplantation has significantly improved survival and enhanced the quality of life of patients with end-stage heart failure. Successful long-term outcomes are predicated on a collaborative effort among patients, transplant teams, and primary care providers (PCPs). Notably, PCPs are increasingly pivotal in post-transplant care, engaging in annual assessments, early recognition of complications, and referral, thus minimizing morbidity and mortality. This article highlights key considerations for PCPs, including indications for heart transplant, immunosuppressive therapy and infection prophylaxis, management of post-transplant complications, psychosocial and lifestyle adjustment, and family planning. This roadmap aims to empower PCPs to deliver optimal care and improve long-term outcomes for heart transplant recipients.
心脏移植显著提高了终末期心力衰竭患者的生存率并改善了其生活质量。成功的长期治疗效果取决于患者、移植团队和初级保健提供者(PCP)之间的共同努力。值得注意的是,PCP在移植后护理中发挥着越来越关键的作用,进行年度评估、早期识别并发症并进行转诊,从而将发病率和死亡率降至最低。本文重点介绍了PCP的关键注意事项,包括心脏移植的适应症、免疫抑制治疗和感染预防、移植后并发症的管理、心理社会和生活方式调整以及计划生育。本指南旨在使PCP有能力为心脏移植受者提供最佳护理并改善长期治疗效果。